News
23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction
Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, including its biobank of customer genetic samples, have been purchased by American biotechnology company Regeneron Pharmaceuticals for a cool $256 million, the highest bid submitted in the once-hot startup’s bankruptcy auction.
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...
Rapidly mutating DNA regions were mapped using a multi-generational family and advanced sequencing tools. Understanding how ...
The African wild dog is one of Africa's most endangered predators. African wild dogs are highly elusive, avoiding human ...
Early Asians walked more than 20,000km from North Asia to South America, making the Asian and the South American closely ...
AI facial recreation just got a major upgrade, as Chinese scientists made a model that can recreate faces using nothing but ...
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Researchers used a genetic database of over 9,600 Han Chinese individuals to train a technological model to reconstruct 3D ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback